度普利尤单抗诱发的玫瑰糠疹。 - Suppr

Suppr

超能文献

Dupilumab-induced pityriasis rosea.

作者信息

Zabel Morgan, Hile Grace A, Shefler Alanna, Harms Paul W, Chan May P, Mancuso Jennifer B

机构信息

College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

University of Michigan Department of Dermatology, Ann Arbor, Michigan.

出版信息

JAAD Case Rep. 2023 Jan 6;33:27-29. doi: 10.1016/j.jdcr.2023.01.001. eCollection 2023 Mar.

DOI:10.1016/j.jdcr.2023.01.001

PMID:36843663

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9945633/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8c/9945633/cdeef8ae8230/gr1.jpg

相似文献

Dupilumab-induced pityriasis rosea.

JAAD Case Rep. 2023 Jan 6;33:27-29. doi: 10.1016/j.jdcr.2023.01.001. eCollection 2023 Mar.

Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.

JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.

An update on pityriasis rosea and other similar childhood exanthems.

Curr Opin Pediatr. 2009 Aug;21(4):481-5. doi: 10.1097/MOP.0b013e32832db96e.

Interventions for pityriasis rosea.

Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis.

JAAD Case Rep. 2024 Jan 19;45:77-78. doi: 10.1016/j.jdcr.2023.12.019. eCollection 2024 Mar.

Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.

Dermatol Online J. 2006 Jan 27;12(1):1.

Study of role of streptococcal throat infection in pityriasis rosea.

Indian J Dermatol. 2008;53(4):171-3. doi: 10.4103/0019-5154.44787.

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Pityriasis Rosea Induced by COVID-19 Vaccination.

Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.

Pityriasis rosea-like adverse reaction to atenolol.

Hum Exp Toxicol. 2016 Mar;35(3):229-31. doi: 10.1177/0960327115580220. Epub 2015 Mar 18.

引用本文的文献

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis.

JAAD Case Rep. 2024 Jan 19;45:77-78. doi: 10.1016/j.jdcr.2023.12.019. eCollection 2024 Mar.

本文引用的文献

Dupilumab-induced erythema nodosum.

JAAD Case Rep. 2021 Nov 17;19:41-43. doi: 10.1016/j.jdcr.2021.11.007. eCollection 2022 Jan.

Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.

Am J Clin Dermatol. 2022 Jan;23(1):61-67. doi: 10.1007/s40257-021-00646-z. Epub 2021 Dec 2.

Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.

Pediatr Dermatol. 2021 Nov;38(6):1500-1505. doi: 10.1111/pde.14820. Epub 2021 Oct 14.

Dupilumab-induced Urticaria.

Dermatol Ther. 2021 Nov;34(6):e15117. doi: 10.1111/dth.15117. Epub 2021 Sep 6.

Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.

Dermatol Ther. 2019 Nov;32(6):e13142. doi: 10.1111/dth.13142. Epub 2019 Nov 21.

Mechanisms of Dupilumab.

Clin Exp Allergy. 2020 Jan;50(1):5-14. doi: 10.1111/cea.13491. Epub 2019 Sep 30.

Dupilumab: First Global Approval.

Drugs. 2017 Jul;77(10):1115-1121. doi: 10.1007/s40265-017-0768-3.

Pityriasis rosea-like drug eruption related to rituximab treatment.

J Dermatol. 2013 Jun;40(6):495-6. doi: 10.1111/1346-8138.12103. Epub 2013 Feb 27.

Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.

Dermatol Online J. 2006 Jan 27;12(1):1.

Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.

J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S240-3. doi: 10.1016/j.jaad.2004.10.888.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Dupilumab-induced pityriasis rosea.

JAAD Case Rep. 2023 Jan 6;33:27-29. doi: 10.1016/j.jdcr.2023.01.001. eCollection 2023 Mar.

Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.

JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.

An update on pityriasis rosea and other similar childhood exanthems.

Curr Opin Pediatr. 2009 Aug;21(4):481-5. doi: 10.1097/MOP.0b013e32832db96e.

Interventions for pityriasis rosea.

Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis.

JAAD Case Rep. 2024 Jan 19;45:77-78. doi: 10.1016/j.jdcr.2023.12.019. eCollection 2024 Mar.

Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.

Dermatol Online J. 2006 Jan 27;12(1):1.

Study of role of streptococcal throat infection in pityriasis rosea.

Indian J Dermatol. 2008;53(4):171-3. doi: 10.4103/0019-5154.44787.

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Pityriasis Rosea Induced by COVID-19 Vaccination.

Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.

Pityriasis rosea-like adverse reaction to atenolol.

Hum Exp Toxicol. 2016 Mar;35(3):229-31. doi: 10.1177/0960327115580220. Epub 2015 Mar 18.

引用本文的文献

Pityriasis rosea-like drug eruption secondary to deucravacitinib.

JAAD Case Rep. 2024 Sep 1;53:63-65. doi: 10.1016/j.jdcr.2024.08.019. eCollection 2024 Nov.

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis.

JAAD Case Rep. 2024 Jan 19;45:77-78. doi: 10.1016/j.jdcr.2023.12.019. eCollection 2024 Mar.

本文引用的文献

Dupilumab-induced erythema nodosum.

JAAD Case Rep. 2021 Nov 17;19:41-43. doi: 10.1016/j.jdcr.2021.11.007. eCollection 2022 Jan.

Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.

Am J Clin Dermatol. 2022 Jan;23(1):61-67. doi: 10.1007/s40257-021-00646-z. Epub 2021 Dec 2.

Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.

Pediatr Dermatol. 2021 Nov;38(6):1500-1505. doi: 10.1111/pde.14820. Epub 2021 Oct 14.

Dupilumab-induced Urticaria.

Dermatol Ther. 2021 Nov;34(6):e15117. doi: 10.1111/dth.15117. Epub 2021 Sep 6.

Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.

Dermatol Ther. 2019 Nov;32(6):e13142. doi: 10.1111/dth.13142. Epub 2019 Nov 21.

Mechanisms of Dupilumab.

Clin Exp Allergy. 2020 Jan;50(1):5-14. doi: 10.1111/cea.13491. Epub 2019 Sep 30.

Dupilumab: First Global Approval.

Drugs. 2017 Jul;77(10):1115-1121. doi: 10.1007/s40265-017-0768-3.

Pityriasis rosea-like drug eruption related to rituximab treatment.

J Dermatol. 2013 Jun;40(6):495-6. doi: 10.1111/1346-8138.12103. Epub 2013 Feb 27.

Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.

Dermatol Online J. 2006 Jan 27;12(1):1.

Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.

J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S240-3. doi: 10.1016/j.jaad.2004.10.888.